Replies to post #65293 on Biotech Values

[amylinterry]

Lame PR ? or "connection"


Insmed has an article in the Wasington Post
better to have an ex Congressman and active PR dept verses
financing or a partner. I wonder if getting delisted will affect Insmed FOB program ?

[DewDiligence]

AIDS advocacy group is angry that US Senate pulled $400M for HIV testing and prevention from the stimulus bill:

http://finance.yahoo.com/news/AHF-Senate-Democrats-Allow-bw-14230616.html